Outlook: Expects revenue growth of 8% year-on-year, inline with the IPM growth of 8% in the second quarter ended September ...

India's largest stent manufacturer, Sahajanand Medical Technologies is also reportedly exploring a public listing on the domestic market ...

This comes after competing private equity firms TPG Capital, Apax Partners, and KKR withdrew their original interest.

Promoters of SMT—the Kotadia family— plan to keep a minority stake after the transaction that would see other shareholders ...

Mumbai: Alkem Laboratories Ltd. has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, Inc to ...

The PE firms are up against Dr Reddy's, which has an alliance with Novartis for marketing some of its off-patent products and ...

The drug is expected to offer nerve regeneration, potentially modifying the disease in diabetic peripheral neuropathy ...

India is grappling with a substantial burden of diabetes-related complications with diabetic peripheral neuropathy being a ...

A media report said that the US Center for Medicare and Medicaid released a preliminary list of 101 generic drugs.

Sonnet BioTherapeutics Holdings ( (SONN) ) has issued an update. Sonnet BioTherapeutics Holdings, Inc. has partnered with ...

Alkem Laboratories said that it has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, to develop, manufacture and commercialise the drug candidate 'SON-080' for the ...